A multicenter, prospective observational RWE study to assess Patient-reported wellbeing using tildrakizumab in a live setting – POSITIVE Study
| type of project | clinical studies |
| status | ongoing - recruiting phase |
| start of project | 2022 |
| end of project | 2024 |
| responsible person | Ieva Saulite |